CochraneBreastCancer

Cochrane Breast Cancer Group

[CochraneBreastCancer @CochraneBCancer]

Platinum-based chemotherapy in the adjuvant and neoadjuvant setting for people with triple-negative breast cancer - https://t.co/zDxFy9VxGq

[CochraneBreastCancer @CochraneBCancer]

New review on radiotherapy compared to no radiotherapy in women diagnosed with breast cancer who have 1 to 3 involved axillary lymph nodes - https://t.co/GWGx4UbdAd

[CochraneBreastCancer @CochraneBCancer]

New review on training health workers in clinical breast examination on early detection of breast cancer in low- and middle-income countries - https://t.co/9qnLsYi9TW

[CochraneBreastCancer @CochraneBCancer]

Updated review on Psychological interventions for women with non-metastatic breast cancer - https://t.co/DD5WEUUs9p. Includes 32 new studies

[The BMJ @bmj_latest]

Clinical trials registers are a key resource for identifying potentially eligible studies for systematic reviews, particularly those that are unpublished.

This paper provides step-by-step guidance on how to conduct systematic searches @KylieEHunter
https://t.co/DKZwy8rBkx

[CochraneBreastCancer @CochraneBCancer]

Pain medications around the time of surgery in women undergoing breast surgery https://t.co/uFqPVWQjQk New systematic review looks at the evidence from 12 RCTs including 1,596 participants. #breastcancer

[CochraneBreastCancer @CochraneBCancer]

Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review - https://t.co/k1qNpqLnha. Includes 8 studies

[CochraneBreastCancer @CochraneBCancer]

Oncoplastic breast-conserving surgery for women with primary breast cancer - https://t.co/gM2ififCoA. New systematic review looks at the evidence from 78 studies

[CochraneBreastCancer @CochraneBCancer]

Partial breast irradiation for early #breastcancer - https://t.co/oLWEo5wsly Updated systematic review from @CochraneBCancer looks at the evidence from 9 studies, which involved 15,187 participants.

[CochraneBreastCancer @CochraneBCancer]

New review available on capecitabine in hormone receptor-positive or hormone receptor-negative breast cancer https://t.co/gikv67keWR. Review includes evidence from 26 studies

[CochraneBreastCancer @CochraneBCancer]

Specialist breast care nurses for support of women with breast cancer #breastcancer - https://t.co/XeKKYIhlQV. Updated systematic review looks at the evidence from 14 studies @Sue_Cruickshank @royalmarsdenNHS @RCNCancerForum

[CochraneBreastCancer @CochraneBCancer]

Weight loss programmes for overweight and obese breast cancer survivors - what are their benefits and harms? https://t.co/DN5fmgJ9bH New @CochraneBCancer systematic review looks at the evidence from 20 relevant studies

[CochraneBreastCancer @CochraneBCancer]

Platinum‐containing regimens for triple‐negative metastatic #breastcancer - https://t.co/5JNopKKUMB Updated #CochranebCancer systematic review looks at the evidence from 10 studies involving 1349 women

[CochraneBreastCancer @CochraneBCancer]

Can you help prioritise a list of new and existing Cochrane Haematology review topics? https://t.co/kLwinzOqXt

[CochraneBreastCancer @CochraneBCancer]

Cochrane Breast Cancer Group announces its top 10 review topics for the Cochrane Library - https://t.co/zZYfAaIbdn

[CochraneBreastCancer @CochraneBCancer]

New review examines indocyanine green angiography (ICGA) vs clinical evaluation in preventing postoperative complications following breast reconstruction after mastectomy - https://t.co/EqYxQXA6kC

[CochraneBreastCancer @CochraneBCancer]

Cochrane is responding rapidly to #covid19 by providing trusted evidence to inform health decisions. Hear what Rapid Reviews are underway - https://t.co/TgK8BudgqJ

[CochraneBreastCancer @CochraneBCancer]

Attention #COVID19 researchers - Doing a living systematic review, living network meta-analysis, or a rapid review? @cochranecollab has launched its COVID-19 Study Register – a one-stop shop for primary research studies on COVID-19. https://t.co/HgKBEvkCQU

[CochraneBreastCancer @CochraneBCancer]

New systematic review - ovarian function suppression for treating premenopausal women with hormone receptor‐positive early breast cancer https://t.co/Uqi0mCmtJI

[CochraneBreastCancer @CochraneBCancer]

Cochrane’s Colloquium 2020 in Toronto is a Patients Included Accredited Event! #CochraneToronto Abstract submissions have started and early registration is open! https://t.co/KGhIT6rpMd